Clinical Trial Pipeline

Clinical Trial Pipeline Monitor

Track the neurodegeneration treatment pipeline in one place.

Track serious treatment programs across Alzheimer's, Parkinson's, ALS, FTD, Huntington's disease, and adjacent mechanisms in one source-linked view.

Browse by disease

Disease-specific views of the main programs, mechanisms, and current movement.

Disease hubAlzheimer's pipeline

Track the mix of amyloid, tau, metabolic, and precision-style Alzheimer's programs worth watching.

10 tracked8 active5 late-stage / approved
Disease hubParkinson's pipeline

Follow Parkinson's programs spanning alpha-synuclein, GBA biology, gene therapy, and mechanistic repurposing.

5 tracked3 active0 late-stage / approved
Disease hubALS pipeline

Track ALS programs across genetic targeting, stress-response biology, cell therapy, and platform-trial bets.

7 tracked5 active5 late-stage / approved
Disease hubFTD pipeline

Track FTD programs anchored in progranulin, GRN replacement, C9 biology, and other genetics-led strategies.

4 tracked1 active1 late-stage / approved
Disease hubHuntington's pipeline

Track Huntington's programs across gene therapy, antisense, allele-selective, and small-molecule huntingtin-lowering approaches.

6 tracked3 active1 late-stage / approved

Recent pipeline changes

Loading pipeline monitor…
No programs match the current filters yet.

About this tracker

Follow source-linked neurodegeneration treatment programmes in one place, with enough context to understand what is moving and why it matters.

  • Programs can be filtered by disease, phase, status, mechanism, or location.
  • Each card keeps source links and a last-verified timestamp.
  • The change feed highlights newly tracked programs and notable status shifts across the pipeline.
Scroll to Top